- Report
- November 2024
- 700 Pages
Global
From €3678EUR$3,995USD£3,094GBP
- Report
- November 2024
- 450 Pages
Global
From €3678EUR$3,995USD£3,094GBP
- Report
- November 2024
- 250 Pages
Global
From €3678EUR$3,995USD£3,094GBP
- Report
- November 2024
- 250 Pages
Global
From €3678EUR$3,995USD£3,094GBP
- Report
- November 2024
- 500 Pages
Global
From €3678EUR$3,995USD£3,094GBP
- Report
- December 2024
- 332 Pages
Global
From €3864EUR$4,197USD£3,250GBP
- Report
- May 2025
- 496 Pages
Global
From €6440EUR$6,995USD£5,417GBP
- Report
- March 2025
- 1048 Pages
Global
From €4418EUR$4,799USD£3,716GBP
- Report
- September 2024
- 972 Pages
Global
From €4418EUR$4,799USD£3,716GBP
- Report
- May 2024
- 311 Pages
Global
From €5352EUR$6,017USD£4,350GBP
- Report
- June 2024
- 359 Pages
Global
From €5352EUR$6,017USD£4,350GBP
- Report
- July 2024
- 266 Pages
Global
From €4557EUR$4,950USD£3,833GBP
- Report
- February 2025
- 434 Pages
Global
From €4557EUR$4,950USD£3,833GBP
- Report
- March 2025
- 320 Pages
Global
From €2762EUR$3,000USD£2,323GBP
- Report
- August 2024
- 180 Pages
Global
From €2209EUR$2,400USD£1,859GBP
- Report
- February 2025
- 287 Pages
Global
From €5063EUR$5,500USD£4,259GBP
- Report
- October 2024
- 122 Pages
Global
From €4281EUR$4,650USD£3,601GBP
- Report
- August 2024
- 111 Pages
Global
From €4281EUR$4,650USD£3,601GBP
- Report
- March 2025
- 198 Pages
Global
From €3264EUR$3,545USD£2,745GBP
€3626EUR$3,939USD£3,050GBP
- Report
- October 2024
- 193 Pages
Global
From €3264EUR$3,545USD£2,745GBP
€3626EUR$3,939USD£3,050GBP

CRISPR Therapeutics is a rapidly growing field within the genomics market. It is a gene-editing technology that uses a modified version of the CRISPR-Cas9 system to modify or replace genes in a living organism. This technology has the potential to revolutionize the way diseases are treated, as it can be used to target and modify specific genes that are responsible for certain diseases. It can also be used to create new treatments for diseases that have no existing treatments.
CRISPR Therapeutics has been used to develop treatments for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. It has also been used to create new treatments for rare diseases, as well as to develop new therapies for existing diseases.
Companies in the CRISPR Therapeutics market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Caribou Biosciences. These companies are working to develop treatments for a variety of diseases, as well as to create new therapies for existing diseases. Show Less Read more